Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetesOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study tested whether early-life antibiotics that disturb the gut microbiota change the incidence of spontaneous autoimmune type 1 diabetes. It used the non-obese diabetic (NOD) mouse, which develops diabetes by destroying pancreatic beta cells. Breeding pairs received a broad antibiotic mixture (streptomycin, colistin, ampicillin) or vancomycin alone in drinking water from conception onward. The gut microbiota was profiled by 16S rRNA sequencing, and intestinal T cell subsets and cytokines were measured.
Who was studied?
The subjects were NOD mice bred under specific pathogen-free conditions. Treatment ran from mating through fetal, postnatal, and adult life until 40 weeks. Across 35 breeding pairs, 148 female and 177 male mice were treated. Microbiota sequencing used feces from 8-week-old mice across the groups. Intestinal lamina propria T cells were isolated from the ileum and colon of 10-week-old mice, with spleen cells as a comparison.
What were the most important findings?
Both antibiotic regimens significantly raised diabetes incidence in male mice. Vancomycin lifted 40-week incidence from 64.3 to 91.4 percent (p equals 0.0004) and the mixture to 92.1 percent. Females, already near 90 percent, showed only a nonsignificant trend. Vancomycin increased Escherichia, Lactobacillus, and Sutterella and decreased Clostridiales, Lachnospiraceae, Prevotellaceae, and Rikenellaceae. Chao1 diversity fell from 1605 to 428, and to 189 with the mixture. Intestinal IL-17-producing CD4 and gamma-delta T cells were nearly eliminated in treated mice.
What are the greatest implications of this study?
The results indicate that partial or near-complete depletion of the gut microbiota early in life can accelerate autoimmune diabetes in genetically susceptible male mice. This supports caution about antibiotic use in pregnancy and infancy. Strikingly, even near-total loss of gut bacteria and intestinal IL-17 cells did not block the diabetogenic lymphocytes, showing the disease can proceed despite major microbiota disruption. The findings are in a spontaneous mouse model, and the authors note human epidemiological evidence for type 1 diabetes remains lacking, so extrapolation to people is uncertain.